Notes / Company

Sandu Pharmaceuticals Ltd.

SANDUPHQ BSE 524703 ISIN INE751D01014 Pharmaceuticals

Fundamentals

Market cap: ₹40 cr
P/E: 25.77×
ROE: 3.69%
Debt / equity: 0.00
Div yield: 2.41%
52-week range: 30.00 — 58.28

Research on Tijori Finance

Company snapshot

Sandu Pharmaceuticals Ltd.

Pharmaceuticals

₹40 cr

P/E 25.76×

Latest quarter · Mar 2025

Sales₹14 cr

Net profit₹0 cr

Op. margin+3.2%

EPS₹0.34

Strength & growth

Debt / equity0.00×

Current ratio2.18×

Sales CAGR+5.5%

EPS CAGR+7.7%

The timeline — 1 note on Sandu Pharmaceuticals Ltd.

June 2026

19 Jun 26 · 3:24 PM IST Lead

Lead · Micro cap

Sandu Pharma faces void after MD Umesh Sandu's sudden death

The ayurvedic drugmaker's promoter and managing director has died, leaving a leadership gap at a nano-cap firm with ₹41 cr market cap and no successor named yet.

Verify on exchange BSE filings for SANDUPHQ NSE filings for SANDUPHQ Tijori Finance company page